USFDA completes inspection at Granules India’s Virginia facility

11 Dec 2017 Evaluate

Granules India’s wholly-owned foreign subsidiary - Granules Pharmaceuticals, Inc. facility located in Chantilly, Virginia, USA has completed its first audit from December 4, 2017 to December 8, 2017 by the US Food and Drug Administration (USFDA) with one observation. Granules Pharmaceuticals, Inc. will respond to this observation within the stipulated time period.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).



Granules India Share Price

554.00 -16.55 (-2.90%)
01-Feb-2026 13:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1614.65
Dr. Reddys Lab 1214.65
Cipla 1316.50
Zydus Lifesciences 883.90
Lupin 2119.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×